The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplificationChaoji Shi, Guoxin Ren, Rong Zhou et al.|BMC Medicine|2024Cited by 7